Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

By Vasikaran S.   Eastell R.   Bruyère O.   Foldes A.   Garnero P.   Griesmacher A.   McClung M.   Morris H.   Silverman S.   Trenti T.   Wahl D.   Cooper C.   Kanis J.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 391-420

Springer Publishing Company

Access to resources Recommend Favorite

Compliance with osteoporosis drug therapy and risk of fracture

By Weycker D.   Macarios D.   Edelsberg J.   Oster G.  

Osteoporosis International, Vol. 18, Iss. 3, 2007-03 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Melanoma Biomarkers: Current Status and Utility in Diagnosis, Prognosis, and Response to Therapy

By Haass Nikolas K.   Smalley Keiran S.M.  

Molecular Diagnosis & Therapy, Vol. 13, Iss. 5, 2009-10 ,pp. : 283-296

Adis International

Access to resources Recommend Favorite

Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women

By Nguyen Tuan   Center Jacqueline   Pocock Nicholas   Eisman John  

Osteoporosis International, Vol. 15, Iss. 1, 2004-01 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Hormone therapy and risk of non-vertebral fracture: Geelong Osteoporosis Study

By Pasco Julie   Kotowicz Mark   Henry Margaret   Sanders Kerrie   Seeman Ego   Nicholson Geoffrey  

Osteoporosis International, Vol. 15, Iss. 6, 2004-06 ,pp. : 434-438

Springer Publishing Company

Access to resources Recommend Favorite